56 Roland Street, Suite 310 Boston, MA 02129-1234 (617) 629-4400 Fax: (617) 629-9100

Home

About Hydrospine, Inc.

Technology

Advisory Board

Investors

Contact Us

	Hydrospine, Inc. is a privately held company developing minimally invasive technologies to address lower back pain without fusion.     Hydrospine is developing an injectable hydrogel system that forms a load-bearing nucleus pulposus analog. The system can be injected in a posterior or posterior-lateral approach through an incision size less than 5 mm in diameter. The hydrogel forms without chemical reaction, and consists of materials that have been shown to be entirely biocompatible.
	Contact Hydrospine for more information.
	Disclaimer: The Hydrospine injectable nucleus technology is an investigational device, and is not currently approved for sale.	Recent News Dr. Gavin Braithwaite and Jason Berlin presented their work on “Surgically relevant in vitro testing of injectable PVA nucleus replacement hydrogels” at the Spine Arthroplasty Symposium (SAS9) in London, England on April 28-May 1, 2009.